Immunological Data Discovery Index
Advanced Search
identifier: 1817116
description:
epitope description:alpha-N-acetylneuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[alpha-N-acetylneuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-N-acylsphingosine
host organism:Homo sapiens
aggregation:
instance of dataset
availability:
available
primaryPublications: 11574105
authorizations:
registration not required
accessURL: http://www.iedb.org/reference/1018069
landingPage: http://www.iedb.org/assay/1817116
type:
Literature
publicationVenue:
J Neurol Sci
dates:
2001
study type: b cell assays
subject species: Homo sapiens
fullName:
R Press
S Matá
F Lolli
J Zhu
T Andersson
H Link
method:
ELISA
name:
Temporal profile of anti-ganglioside antibodies and their relation to clinical parameters and treatment in Guillain-Barré syndrome.
description:
In some patients, antibody levels rose steadily to a peak at Day 40 or 90 after disease onset, then decreased. In other patients, levels remained stable. Patients with antibody peaks had higher disability scores and worse clinical outcomes and axonal damage compared to patients without peak antibody titers.

Feedback?

If you are having problems using our tools, or if you would just like to send us some feedback, please post your questions on Feedback.